skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
XELIRI Regimen (Code C11602)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: XELIRI Regimen

Definition: A chemotherapy regimen containing capecitabine and irinotecan used in the treatment of colorectal, esophageal and gastric cancer.

Label: XELIRI Regimen

NCI Thesaurus Code: C11602 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C3489692  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Capecitabine/Irinotecan Regimen
XELIRI Regimen
Xeloda/Camptosar Regimen

External Source Codes: 
PDQ Closed Trial Search ID 759411
PDQ Open Trial Search ID 759411 (check for NCI PDQ open clinical trial info)
UMLS CUI C3489692

Other Properties:
     Name Value (qualifiers indented underneath)
code C11602
Legacy_Concept_Name Capecitabine_Irinotecan
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom